Fat embolism: an experimental study (II). Evaluation of smooth muscle relaxants in its treatment.
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use*; D000818:Animals; D001285:Atropine / Q000627:therapeutic use*; D004562:Electrocardiography; D004620:Embolism, Fat / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D004837:Epinephrine / Q000627:therapeutic use*; D004878:Ergotamine / Q000627:therapeutic use*; D007275:Injections, Intravenous; D008055:Lipids; D008168:Lung / Q000473:pathology; D009132:Muscles / Q000627:therapeutic use*; D009206:Myocardium / Q000473:pathology; D010208:Papaverine / Q000627:therapeutic use*; D011398:Promethazine / Q000627:therapeutic use*; D011817:Rabbits
D008055:Lipids; D001285:Atropine; D000324:Adrenocorticotropic Hormone; D010208:Papaverine; D011398:Promethazine; D004878:Ergotamine; D004837:Epinephrine